This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. shed 4.3% to $6.42 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 17,461.32 and the Dow Jones Industrial Average rising 0.7% to 40,527.62.
Novavax Inc. closed 73.1% below its 52-week high of $23.86, which the company reached on June 6th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.4% to $155.91, Pfizer Inc. rose 3.2% to $23.79, and Merck & Co. Inc. rose 1.83% to $84.71.
Trading volume totaled 5.0 million, compared to the 50-day average of 5.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 29, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。